Agenda Details

Genome editing technologies have reshaped our ability to modify genomes, bringing the promise of new therapies for human diseases within reach. In this symposium, speakers will highlight recent technological advances in the toolbox of CRISPR and non-CRISPR enzymes capable of making small and large genetic edits. These diverse platforms are being optimized in the pursuit of building highly precise genome editors with low genotoxicity. Our speakers will also discuss how these technologies will, and already are, having an impact in the clinic.